Catechol O-methyltransferase. 12. Affinity labeling the active site with the oxidation products of 5,6-dihydroxyindole
作者:Ronald T. Borchardt、Pramila Bhatia
DOI:10.1021/jm00345a013
日期:1982.3
positions 4 or 7 on the aminochrome. Considering the number of potential electrophilic centers on the basic aminochrome structure, the site of the reaction might change depending on the aromaticsubstitution pattern. The preferred pathway of reaction may be determined in part by the juxtaposition of the protein nucleophile to the possible sites of attack on the electrophilic ligand but also in part on the
USE OF NEURAL STEM CELLS FOR TREATMENT OF MALIGNANCY
申请人:Crawford Susan E.
公开号:US20140058184A1
公开(公告)日:2014-02-27
An improved method for treatment of malignancies is based on the interaction between nerve cells and angiogenesis of malignancies. In general, the method comprises: (1) harvesting neural stem cells; (2) culturing neural stem cells under conditions such that the cells proliferate while retaining their ability to differentiate; (3) applying a biocompatible adhesive to a post-surgical site of a malignancy; and (4) following the application of the biocompatible adhesive to the post-surgical site of the malignancy, applying the cultured neural stem cells to the post-surgical site of the malignancy to remove residual tumor cells and to induce endothelial cell apoptosis. The method can further comprise the administration of a therapeutically effective quantity of at least one anti-neoplastic therapeutic agent or administration of a therapeutically effective quantity of anti-neoplastic ionizing radiation. The invention further encompasses kits for use in treating malignancies.
COATED PARTICLES FOR DRUG DELIVERY
申请人:Dana-Farber Cancer Institute, Inc.
公开号:US20170266123A1
公开(公告)日:2017-09-21
In one aspect, a particle comprising a core containing at least one pharmaceutically active agent and a coating covering the surface of the particle that comprises a biocompatible adhesive polymer is provided. The core may comprise two or more components, such as two pharmaceutically active agents or a pharmaceutically active agent and a major constituent of the core, having at least one dissimilar chemical or physical property (e.g., molecular weight, solubility, c Log P). In some such embodiments, placement of the uncoated core in certain environments results in the rapid release of a component (e.g., a pharmaceutically active agent) from and/or destabilization and breakdown of the core. In some embodiments, the biocompatible adhesive polymer in the coating acts as a molecular glue to stabilize the core and/or alter the release kinetics of at least one pharmaceutically active agent.
US9637597B2
申请人:——
公开号:US9637597B2
公开(公告)日:2017-05-02
708. Melanin and its precursors. Part VII. Synthesis of methylated 5 : 6-dihydroxyindoles, β-(4 : 5-dihydrox-2-methylphenyl)alanine, and related amines